We are live on
!
Find out more
LA
LM Advisors Portfolio holdings
AUM
$6.33M
1-Year Est. Return
20.74%
This Fund
S&P 500
This Quarter
Est. Return
+4.57%
1 Year Est. Return
+20.74%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$492M
AUM Growth
-$61.3B
(-99%)
Cap. Flow
-$582M
Cap. Flow
% of AUM
-118.38%
Top 10 Holdings %
Top 10 Hldgs %
51%
Holding
186
New
14
Increased
21
Reduced
88
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BlackRock Health Sciences Trust II
BMEZ
|
+$1.34M |
| 2 |
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
|
+$1.15M |
| 3 |
Morgan Stanley Direct Lending Fund
MSDL
|
+$819K |
| 4 |
NVIDIA
NVDA
|
+$795K |
| 5 |
ACP
abrdn Income Credit Strategies Fund
ACP
|
+$720K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$550M |
| 2 |
Amazon
AMZN
|
+$5.79M |
| 3 |
Invesco Russell 1000 Dynamic Multifactor ETF
OMFL
|
+$3.66M |
| 4 |
Costco
COST
|
+$3.49M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$2.29M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.11% |
| 2 | Consumer Discretionary | 10.04% |
| 3 | Communication Services | 8.65% |
| 4 | Financials | 7.11% |
| 5 | Healthcare | 3.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
176
Gilead Sciences
GILD
$161B
| – | – |
-4,197
| Closed | -$550M |
|
177
General Motors
GM
$74.7B
| – | – |
-7,287
| Closed | -$339K |
|
178
Generac Holdings
GNRC
$11.9B
| – | – |
-5,263
| Closed | -$696K |
|
179
iShares Global Healthcare ETF
IXJ
$4.11B
| – | – |
-4,806
| Closed | -$294K |
|
180
Lowe's Companies
LOW
$116B
| – | – |
-1,200
| Closed | -$265K |
|
|
NVO
181
Novo Nordisk
NVO
$216B
| – | – |
-1,529
| Closed | -$218K |
|
|
SCHW
182
Charles Schwab
SCHW
$177B
| – | – |
-5,280
| Closed | -$389K |
|
183
Shell
SHEL
$245B
| – | – |
-3,340
| Closed | -$241K |
|
184
Vanguard FTSE Developed Markets ETF
VEA
$226B
| – | – |
-4,394
| Closed | -$217K |
|
185
Vanguard FTSE Pacific ETF
VPL
$8.05B
| – | – |
-2,910
| Closed | -$216K |
|
|
FSD
186
DELISTED
FIRST TRUST HIGH INCOME LONG/SHORT FUND
FSD
| – | – |
-71,529
| Closed | -$883K |
|
Similar funds
OFC
SA
GFM
PFGWM
BM
WI
GCM
SAS
LM Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, LM Advisors held 186 positions worth $492M, down 99% from $61.8B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
LM Advisors withdrew a net $582M in Q3 2024, closing 15 positions and reducing 88 holdings. Its most notable exit was Gilead Sciences, an estimated $550M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, LM Advisors opened a new position in BlackRock Health Sciences Trust II worth $1.35M.
- LM Advisors's largest Q3 2024 buy was BlackRock Health Sciences Trust II: 85,283 shares worth $1.35M.
- LM Advisors added most to NVIDIA in Q3 2024, an estimated $795K increase.
- LM Advisors's biggest Q3 2024 reduction was Amazon, cutting an estimated $5.79M.
- LM Advisors fully exited Gilead Sciences in Q3 2024, selling an estimated $550M.
- LM Advisors's ten largest holdings make up 51% of its $492M portfolio in Q3 2024.
- LM Advisors opened 14 new positions and closed 15 in Q3 2024.
- LM Advisors's portfolio value fell 99% quarter-over-quarter to $492M.
Based on LM Advisors's 13F filing for Q3 2024, filed 7 Nov 2024.